Allosteric modulation of β-cell M3muscarinic acetylcholine receptors greatly improves glucose homeostasis in lean and obese mice

Authors:

Abstract
Significance: Type 2 diabetes (T2D) has emerged as a major threat to human health worldwide. In T2D, pancreatic β cells are unable to release sufficient amounts of insulin to maintain physiological blood glucose levels. Acetylcholine (ACh) stimulates insulin release from mouse and human pancreatic β cells by activating a cell surface receptor known as M3muscarinic ACh receptor (M3R). In the present study, we show that a drug that binds to an allosteric site on the M3R (a site distinct from the ACh-binding site) greatly enhances ACh-induced, M3R-mediated insulin release and improves glucose homeostasis in obese, glucose-intolerant mice. This proof-of-concept study strongly suggests that positive allosteric modulators of M3R function may prove beneficial for the treatment of T2D.
Funding Information
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK075021)

This publication has 34 references indexed in Scilit: